
--- Page 1 ---
P.2033 FINAL DIAGNOSIS: part 1: Left sentinel lymph node #1, biopsy - One (1) LYmph nODe. nEgATivE FOR tUmOR (0/1). Part 2: Left sentinel Lymph noDe #2, biopsy -- Eleven Lymph nodes, negative for tumor (o/11). Part 3: _LEet breast, segmental mastectomy - A. iNFILTRATING DUCT CARCINOmA, 0.8 X 0.7 X 0.6 CM B. nOttingham scOre: 7/9 (tusules - 2, nucleI - 2, mitoses - 3). C.  NO LYMPHOVASCULAR INVA$ION IDENTIFIED D. Ductal Carcinoma in Situ, Cribriform type. nuclear GraDe 2, present In The surrounding BREASt TISSUE AnD ASSOCiATED WITH mIcROCALCIFIcATIONS. E. SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA ANO DUCTAL CARCINOMA IN SITU. F. Changes consistent with previous core biopsy site. G. tumor is estrogen receptor positive, progesterone receptor focally and weakLy pOsitive anD.her-2/neu IS negatIvE, sCOre: 0. H. FIBrOcystic Changes. Thermal effect. Je0-0-3 I. c areinoma, mifi9r^aHwg olutl nts 85oo/3 PARt 4: Left BrEaSt, new POsteRiOr marGIn, eXcISiOn - A.  NegatIve fOr tUmOr. sin: srust,nts c50.9 3/13/11 h B. Fibrocystic changes. SYNOPTIC - PRImARY iNVASIVE CARCINOMA OF BREAST LAteraLIty: Lett PROCEDURE: Segmental LOCATION: Not specified SIZE OF TUMOR:  Maximum dimension invasive component: 0.8 cm MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasIve component): No Ductal adenocarcinoma, NOS NOTTINGHAM SCORE: Nuclear grade: 2 Tubule fomation: 2 Mitolic activity score: 3 Total Nottingham score: 7 Nottingham grade (1. 2. 3): 2 ANGIOLYMPHATiC INVASION: No DERmAl LymphATIc iNVASiON: Not applicable CALCIFICATION: Yes, malignant zones Tumor type, in situ: Cribriform SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: No SURG MARGINS INVOLVED BY IN SITU COMPONENT:  No PAgET'S DISEASE OF NIpPLE: No Lymph noDes positive: 0 LymPh nODeS EXAMINED: METHOD(S) OF LYMPH NODE EXAMINATION: 11 H/E stain SENTINEL NODE METASTASIS: 3//3/1 NON-NEOPLASTIC BREAST TISSUE: FCD No t Stage, pathologic: N stage, pathologic: pT1b m stage, pathologic: pNO UUID:EBAB36DE-A97F-4F8B-806C-EF182519933A Estrogen receptors: pMX TCGA-BH-A0DX-01A-PR Redacted pRogesTerone recepTOrS: poshive HCR2/neU: posltlve zero or 1+